Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement regulatory proteins and autoimmunity.

Wen-Chao Song1

  • 1Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Rm 1254 BRBII/III, 421 Curie Blvd, Philadelphia, PA 19104, USA. song@spirit.gcrc.upenn.edu

Autoimmunity
|August 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of atypical hemolytic uremic syndrome and C3 glomerulopathy in mice by hepatic expression of factor D.

Blood advances·2026
Same author

A spatial atlas of the complement system uncovers unique expression patterns in postnatal brain development in mice.

Nature communications·2025
Same author

Staged Thumb Reconstruction Via Primary Ectopic Banking of Detached Skeletal Elements and Amputated Thumbs With Secondary Replantation.

The Journal of craniofacial surgery·2025
Same author

Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis.

Frontiers in immunology·2025
Same author

Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1-5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy.

ImmunoHorizons·2025
Same author

Therapeutic targeting of factor D and MASP3 in complement-mediated diseases: Lessons learned from mouse studies.

European journal of immunology·2024
Same journal

CCDC77 and SLC45A3 mediate the genetic mechanism of Hashimoto's thyroiditis through IL-6.

Autoimmunity·2026
Same journal

Multi-cohort transcriptomic analysis with machine learning identifies interferon-related candidate genes in systemic lupus erythematosus.

Autoimmunity·2026
Same journal

IgA Vasculitis with necrotizing arteritis: a multicenter retrospective study from the French Vasculitis Study Group and systematic review of the literature.

Autoimmunity·2026
Same journal

Global research trends in ferroptosis in autoimmune diseases: a bibliometric and visual analysis (2018-2025).

Autoimmunity·2026
Same journal

Monocyte exhaustion associated with systemic lupus erythematosus.

Autoimmunity·2026
Same journal

Statement of Retraction: Long non-coding RNA LINC00265 promotes proliferation, apoptosis, and inflammation of chondrocytes in osteoarthritis by sponging miR-101-3p.

Autoimmunity·2026
See all related articles

The complement system impacts autoimmunity by causing inflammation and aiding in the clearance of apoptotic cells. Membrane complement regulatory proteins may suppress autoimmune diseases through various mechanisms.

Area of Science:

  • Immunology
  • Autoimmunity research

Background:

  • The complement system plays a dual role in autoimmunity.
  • Activated complement exacerbates inflammatory tissue injury in autoimmune diseases.
  • Deficiencies in early classical pathway components (C1q, C4, C2) increase systemic autoimmunity risk.

Purpose of the Study:

  • To explore the multifaceted involvement of the complement system in autoimmunity.
  • To investigate the role of membrane complement regulatory proteins in autoimmune disease pathogenesis.

Main Methods:

  • Review of existing literature and recent studies.
  • Analysis of data from transgenic mouse models.

Main Results:

  • Activated complement drives inflammatory tissue damage in autoimmune conditions.

Related Experiment Videos

  • Early complement component deficiencies are linked to higher systemic autoimmunity risk.
  • Membrane complement regulatory proteins modulate autoimmune injury through complement-dependent and -independent pathways.

    • Conclusions:

    • The complement system is a critical factor in autoimmunity.
    • Membrane complement regulatory proteins offer potential therapeutic targets for suppressing autoimmune diseases.